ATE221783T1 - Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten - Google Patents

Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten

Info

Publication number
ATE221783T1
ATE221783T1 AT96914505T AT96914505T ATE221783T1 AT E221783 T1 ATE221783 T1 AT E221783T1 AT 96914505 T AT96914505 T AT 96914505T AT 96914505 T AT96914505 T AT 96914505T AT E221783 T1 ATE221783 T1 AT E221783T1
Authority
AT
Austria
Prior art keywords
arginine
lactobacillus plantarum
pharmaceutical compositions
compositions containing
containing lactobacillus
Prior art date
Application number
AT96914505T
Other languages
English (en)
Inventor
Diya Adawi
Bengt Jeppson
Goeran Molin
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Application granted granted Critical
Publication of ATE221783T1 publication Critical patent/ATE221783T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT96914505T 1995-05-09 1996-05-08 Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten ATE221783T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9501719A SE9501719D0 (sv) 1995-05-09 1995-05-09 Pharmaceutical composition
PCT/SE1996/000603 WO1996035440A1 (en) 1995-05-09 1996-05-08 Pharmaceutical composition comprising lactobacillus plantarum and arginine

Publications (1)

Publication Number Publication Date
ATE221783T1 true ATE221783T1 (de) 2002-08-15

Family

ID=20398250

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96914505T ATE221783T1 (de) 1995-05-09 1996-05-08 Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten

Country Status (16)

Country Link
EP (1) EP0825869B1 (de)
JP (1) JP4058560B2 (de)
KR (1) KR19990008403A (de)
CN (1) CN1152678C (de)
AT (1) ATE221783T1 (de)
AU (1) AU704886B2 (de)
BR (1) BR9608284A (de)
CA (1) CA2220498A1 (de)
DE (2) DE69622855T2 (de)
EE (1) EE03597B1 (de)
ES (1) ES2112818T3 (de)
GR (1) GR980300028T1 (de)
NO (1) NO317668B1 (de)
PL (1) PL184603B1 (de)
SE (1) SE9501719D0 (de)
WO (1) WO1996035440A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100376954B1 (ko) * 1995-07-31 2003-07-18 프로비 에이비 장에서집락화하는유산간균
ATE348626T1 (de) 2000-03-24 2007-01-15 Nestle Sa Milchsäurebakterium zur prävention der bauchfellentzündung
KR100585391B1 (ko) * 2002-01-24 2006-06-01 주식회사 프로바이오닉 돼지 전염성위장염 (TGE) 코로나바이러스 및 유해 미생물 억제 활성을 갖는 신규 락토바실러스 프란타럼 Probio-38 및 이를 함유하는 생균활성제
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
WO2005094848A1 (ja) 2004-03-31 2005-10-13 Calpis Co., Ltd. 肝障害予防又は抑制剤及び肝障害予防又は抑制用機能性食品
KR100592717B1 (ko) * 2004-11-20 2006-06-26 주식회사 알엔에이 간 손상 보호 및 예방에 유용한 활성을 갖는 조성물
CN1322111C (zh) * 2004-12-17 2007-06-20 上海交大昂立股份有限公司 一种植物乳杆菌
CN100337653C (zh) * 2004-12-21 2007-09-19 上海交大昂立股份有限公司 一种含有植物乳杆菌的组合物
DK1931363T3 (en) * 2005-09-28 2016-02-22 Nordisk Rebalance As Treatment of IBD using both probiotic bacteria and fermented cereal as behandlingseffektorer
JP5413819B2 (ja) * 2008-02-08 2014-02-12 国立大学法人広島大学 肝機能改善剤およびその製造用ツール、ならびにこれらの利用
KR101075557B1 (ko) 2008-12-03 2011-10-20 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
KR101075558B1 (ko) * 2008-12-03 2011-10-20 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
JP5823695B2 (ja) * 2008-12-03 2015-11-25 国立大学法人広島大学 肝機能障害予防剤
KR101255050B1 (ko) 2009-07-14 2013-04-16 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
KR101486999B1 (ko) 2009-07-22 2015-01-28 씨제이제일제당 주식회사 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
CN102618456B (zh) * 2012-02-28 2013-08-21 江南大学 一种能够缓解慢性酒精性肝损伤的鼠李糖乳杆菌及其用途
TWI463986B (zh) * 2012-08-29 2014-12-11 Univ China Medical 胚芽乳酸桿菌ｃｍｕ９９５菌株之新用途
WO2018195067A1 (en) 2017-04-17 2018-10-25 The University Of Chicago Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease
EP4444332A1 (de) * 2021-12-09 2024-10-16 Société des Produits Nestlé S.A. Lactobacillus acidophilus zur erhöhung der agmatin-produktion durch mikrobiota

Also Published As

Publication number Publication date
BR9608284A (pt) 1999-06-08
CA2220498A1 (en) 1996-11-14
PL184603B1 (pl) 2002-11-29
AU5784696A (en) 1996-11-29
WO1996035440A1 (en) 1996-11-14
NO975136D0 (no) 1997-11-07
NO975136L (no) 1997-11-07
GR980300028T1 (en) 1998-04-30
EP0825869A1 (de) 1998-03-04
CN1190346A (zh) 1998-08-12
DE69622855T2 (de) 2003-04-10
DE825869T1 (de) 1998-07-16
NO317668B1 (no) 2004-11-29
EE9700269A (et) 1998-04-15
AU704886B2 (en) 1999-05-06
JPH11504936A (ja) 1999-05-11
ES2112818T1 (es) 1998-04-16
KR19990008403A (ko) 1999-01-25
CN1152678C (zh) 2004-06-09
JP4058560B2 (ja) 2008-03-12
ES2112818T3 (es) 2003-02-16
DE69622855D1 (de) 2002-09-12
EE03597B1 (et) 2002-02-15
EP0825869B1 (de) 2002-08-07
PL323320A1 (en) 1998-03-16
SE9501719D0 (sv) 1995-05-09

Similar Documents

Publication Publication Date Title
DE69622855D1 (de) Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten
AR016798A1 (es) Uso de una cepa de lactobacillus para la elaboracion de un medicamento
HU9603251D0 (en) Lactobacillus strains of human origin, their compositions and uses thereof
ID30071A (id) Pemberian oral lactobacillus untuk pengobatan dan pencegahan infeksi urogental
ATE407687T1 (de) Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids
HUP9901707A2 (hu) Gasztrointesztinális rendellenességek megelőzésére és kezelésére szolgáló gyógyászati, és diétás készítmények
WO2002005829A3 (en) Methods and formultations with probiotic microorganisms and medicaments
DK1005353T3 (da) Farmaceutisk præparat omfattende Lactobacillus casei rhamnosus
HRP920632B1 (en) Oral composition for the treatment of inflammatory bowel deseases
BG101118A (en) Therapeutical compounds
HU9603042D0 (en) Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration
ZA947894B (en) Compounds for medicinal use
DE60012521D1 (de) BAKTERIENSTAMM LACTOBACILLUS ACIDOPHILUS N.V. EP 317/402 NARINE, WELCHER ZUR HERSTELLUNG VON ZUSAMMENSETZUNGEN UND VON DIäTETISCHEN, THERAPEUTISCHEN UND PROPHYLAKTISCHEN PRODUKTEN ZUR BEHANDLUNG VON DYSBAKTERIOSE UND DEREN FOLGEN VERWENDET WIRD
JPS6483025A (en) Blended preparation of drug-resistant live bacterium agent for controlling intestinal function and antibacterial agent
BR9506507A (pt) Forma galênica de derivados de 5-nitro-imadazol composiçoes farmacêuticas microgrânulos gastro-protegidos de derivados de 5-nitro-imidazol e produto da combinaçao
WO1999003509A3 (de) Pharmazeutische mittel enthaltend perfluoralkylgruppenhaltige trijodaromaten und ihre verwendung in der tumortherapie und interventionellen radiologie
Samuel Paediatrics Forum. Acute diarrhoea
MD20010055A (ro) Preparat microbian sanogenic pentru profilaxia şi tratamentul disbacteriozei intestinale
MD20010076A (ro) Preparat microbian sanogenic pentru asanarea tubului digestiv şi tratamentul disbacteriozei
IT1274733B (it) Ceppo del genere lactobacillus di origine umana e suoi usi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties